Comments on: UniXell Biotechnology announces the first patient dosed with UX-DA001, an investigational autologous iPSC based cell therapy for the treatment of Parkinson’s disease, in its Phase 1 study

Comments on: UniXell Biotechnology announces the first patient dosed with UX-DA001, an investigational autologous iPSC based cell therapy for the treatment of Parkinson’s disease, in its Phase 1 study https://9krapalm.com/unixell-biotechnology-announces-the-first-patient-dosed-with-ux-da001-an-investigational-autologous-ipsc-based-cell-therapy-for-the-treatment-of-parkinsons-disease-in-its-phase-1-study/ เสิร์ฟข่าวไอที อัปเดตเทคโนโลยีสไตล์ @krapalm Fri, 23 May 2025 11:44:41 +0000 hourly 1 https://wordpress.org/?v=7.0.2